OABI
OmniAb, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.33
−8.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 28.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.42x
- Price / sales
- 16.38x
- Price / cash flow
- -35.62x
Enterprise value
- Enterprise value
- $596.5M
- EV / sales
- 15.52x
- EV / EBITDA
- -23.43x
- EV / EBIT
- -12.34x
- Market cap
- $629.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026